Aerie Pharmaceuticals reported $7.12M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Aerie Pharmaceuticals AERI:US $ 7.12M 0.22M
Amarin AMRN:US $ 0.03M 0.02M
Antares Pharma ATRS:US $ 1.14M 0.17M
Coherus Biosciences CHRS:US $ 5.75M 0.1M
Endo International Ordinary Shares ENDP:US $ 141.64M 6.95M
Flexion Therapeutics FLXN:US $ 5.18M 9K
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Insmed INSM:US $ 10.32M 2.76M
JAZZ PHA JAZZ:US $ 69.82M 41.24M
Novartis NOVN:VX 201M 1000K
Pacira Pharmaceuticals PCRX:US $ 7.02M 0.05M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Revance Therapeutics RVNC:US $ 1.57M 9K
Supernus Pharmaceuticals SUPN:US $ 5.47M 0.4M
Teva Pharmaceutical Industries TEVA:US $ 240M 1M
Valeant Pharmaceuticals VRX:CN $ 369M 5M
Zoetis ZTS:US $ 57M 0M
Zogenix ZGNX:US $ 3.79M 0.05M